Search clinical trials for: LBH589
Total 129 results
-
Novartis PharmaceuticalsTerminatedLeukemia-Lymphoma, Adult T-Cell | Cutaneous T-Cell LymphomaJapan
-
Abdullah KutlarSecura Bio, Inc.RecruitingSickle Cell DiseaseUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...NovartisTerminatedBrain Metastasis | Recurrent Glioma | High-grade MeningiomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
Anne Beaven, MDNovartisTerminatedDiffuse Large B-cell LymphomaUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER-2 Positive Breast CancerBelgium, Netherlands, Australia, Italy, United States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis PharmaceuticalsCompletedMultiple MyelomaUnited States
-
Novartis PharmaceuticalsCompletedLymphoma | Leukemia | Multiple MyelomaUnited States, Germany, Australia
-
Novartis PharmaceuticalsCompletedCancer | Advanced Solid TumorJapan
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML)Japan
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Sweden, Netherlands, United States, United Kingdom
-
Roswell Park Cancer InstituteNovartisTerminatedHodgkin's Lymphoma | Non-Hodgkin's LymphomaUnited States
-
Translational Research in OncologyCompletedBreast CancerUnited States
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI)CompletedGliomaUnited States
-
Novartis PharmaceuticalsCompletedCutaneous T-Cell LymphomaItaly, Spain, Belgium, Canada, Australia, Germany, Switzerland, United States, France, Argentina, Finland, Hungary
-
Novartis PharmaceuticalsTerminatedCutaneous T-Cell LymphomaUnited States
-
Novartis PharmaceuticalsCompletedCancerUnited States, Switzerland, Sweden
-
Johann Wolfgang Goethe University HospitalUnknownAcute Myeloid Leukemia | Myelodysplastic SyndromeGermany
-
Neurological Surgery, P.C.TerminatedRecurrent Malignant GliomasUnited States
-
SCRI Development Innovations, LLCNovartis PharmaceuticalsTerminated
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedMelanoma | Malignant MelanomaUnited States
-
Ronald HoffmanNovartisUnknownPrimary Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Post-Essential Thrombocythemia Related MyelofibrosisUnited States
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
Novartis PharmaceuticalsTerminatedMultiple MyelomaUnited States, Germany
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedWaldenstrom's MacroglobulinemiaUnited States
-
Radboud University Medical CenterCompletedHepatitis C | Deglutition DisordersNetherlands
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B-cell LymphomaItaly
-
NovartisCompletedCutaneous T-Cell Lymphoma | TumorsJapan
-
Roswell Park Cancer InstituteNovartisTerminatedClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Recurrent Renal Cell CancerUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Netherlands, United States, United Kingdom
-
University of AarhusMassachusetts General Hospital; Novartis; Aarhus University Hospital; Monash University and other collaboratorsCompleted
-
SCRI Development Innovations, LLCNovartisCompleted
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
Novartis PharmaceuticalsCompletedMultiple MyelomaGermany, Italy, Spain, Canada, United States, Australia
-
University of Wisconsin, MadisonNovartis PharmaceuticalsTerminated
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsTerminatedMyelodysplastic SyndromeUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedGraft-Versus-Host DiseaseUnited States
-
Novartis PharmaceuticalsCompletedHodgkin's LymphomaUnited States, Belgium, Germany, Canada, Singapore, Netherlands, France, Australia, Russian Federation, Israel, Brazil, Italy, New Zealand, Poland
-
Duke UniversityNovartisWithdrawn
-
Peter MacCallum Cancer Centre, AustraliaCompletedMultiple Myeloma | Nodal Lymphoma | Lymphoma With Cutaneous Involvement | Lymphoma in Leukemic Phase | Marrow Involvement With LymphomaAustralia
-
Novartis PharmaceuticalsTerminatedLeukemia, Myeloid, ChronicUnited States, Germany
-
Novartis PharmaceuticalsCompletedEsophageal Cancer | Prostate Cancer | Head & Neck CancerBelgium
-
Technical University of MunichNovartisTerminated
-
Novartis PharmaceuticalsCompletedAcute Myelogenous Leukemia | Refractory LeukemiaBelgium, Korea, Republic of, Turkey, Germany, Australia, France, Switzerland, United Kingdom, Spain, Italy, Peru, United States
-
Novartis PharmaceuticalsCompletedClassical Hodgkin's LymphomaSpain, France, Belgium, Italy, Israel, Germany, United States, Australia, Brazil, Singapore, Malaysia, New Zealand, United Kingdom
-
Novartis PharmaceuticalsTerminatedChronic Myeloid Leukemia in Chronic PhaseBelgium, Germany
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia (AML)Germany, Spain, United States
-
Anand JillellaNovartis PharmaceuticalsCompletedMantle Cell LymphomaUnited States